May 4 2012
Topera Medical today announced that its FDA-cleared RhythmView™ 3D
mapping and diagnostic system will be featured in 16 scientific
presentations at the 33rd Annual Scientific Sessions of the
Heart Rhythm Society (HRS), May 9-12 in Boston. The presentations will
provide clinicians with additional information about the electrical
source of atrial arrhythmias and will also introduce information on
sources that drive ventricular arrhythmias.
"RhythmView's contribution to these presentations speaks to the
expanding interest in applying this 3D mapping platform in clinical
practice," said Edward Kerslake, Topera Medical's Chief Executive
Officer. "RhythmView's ability to resolve rotors in ventricular
arrhythmias will be reported for the first time. This represents an
interesting application for RhythmView beyond the atrial rotor mapping
previously reported, and is a logical extension of our platform
technology. As we prepare for the commercial launch in early 2013, we
are pleased to see Topera's technology taking a lead role in
transforming the way electrophysiology procedures are performed."
Schedule of scientific presentations (All times are Eastern time,
with events to be held at the Boston Convention Center):
Wednesday, May 9
1:45 p.m. AF Summit at the World Trade Center
Mapping Based Catheter Ablation of Rotors in Long Standing Persistent
AF.
3:00 p.m. in room 160A
AB02-03 - Targeted Ablation at Sources Alone (Focal Impulse and Rotor
Modulation, FIRM) Acutely Terminates or Slows Human Atrial Fibrillation.
5:45 p.m. in the Exhibit Hall
PO1-105 - Correlation of Electrogram Characteristics and Localized
Sources for Human AF.
PO1-126 -Ventricular Fibrillation Rotors Are Located in Both
Ventricles in Patients with and without Structural Heart Disease.
Thursday, May 10
9:30 a.m. in the Exhibit Hall
PO2-52 - Determinants of the Number of Localized Sources for Human
Atrial Fibrillation.
PO2-62 - Rotors and Focal Impulses: Mechanisms to Explain Atrial
Fibrillation Initiation Remote from Triggers.
PO2-116 - Physiologically-Guided Ablation Reduces Need for
Conventional Ablation of Atrial Fibrillation.
PO2-149 - Percutaneous Detection of Electrical Rotors That Drive
Human Ventricular Fibrillation.
1:30 p.m. in room 253A
AB14-01 - Human Atrial Fibrillation Is Initiated by Rotors or
Repetitive Focal beats that are Consistent for Multiple Triggers.
2:00 p.m. in the Exhibit Hall
PO3-61 - Identification of Localized Sources for Human Atrial
Fibrillation from the Surface Electrocardiogram.
PO3-150 - Increased Global Surface ECG Phase Correlation Predicts
Human Ventricular Fibrillation Rotors.
2:45 p.m. in room 210C
AB03 - Success of Focal Impulse and Rotor Modulation (FIRM) for Human
Atrial Fibrillation Reflects the Adequacy of Basket Recordings.
3:45 p.m. in the Exhibit Hall
MPO2-04 - Rotors and Focal Beat Sources for Human Atrial Fibrillation
Migrate Within Limited Constrained Areas.
Friday, May 11
12:30 p.m. in room 158
Classifying Fractionated Electrograms in Human Atrial Fibrillation
Using Monophasic Action Potentials and Activation Mapping: Evidence for
Localized Drivers, Rate Acceleration, and Nonlocal Signal Etiologies.
2:00 p.m. in room 160A
AB02-03 - Targeted Ablation at Sources Alone (Focal Impulse and Rotor
Modulation, FIRM) Acutely Terminates or Slows Human Atrial Fibrillation.
2:30 p.m. in room 253A
AB35-05 - Sustaining Rotors and Focal Beats for Human Atrial
Fibrillation Are Unrelated to Sites of Fractionated Electrograms.
Women gain stronger heart protection from exercise than men, study reveals